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Objective: Insulin protects cardiomyocytes from apoptosis. Insulin resistance usually refers to a defect in the ability of insulin to stimulate glucose
uptake. It is unknown, however, whether or not insulin resistance compromises the cell-protective effect of the hormone. Caspases are a family of
cysteine proteases that regulate apoptosis.We explored the effects of insulin resistance on hypoxia-induced caspase-3 activation in cardiomyocytes.
Methods: Experiments were performed in cultured neonatal rat cardiomyocytes. Insulin resistance was induced by treating cardiac myocytes
with isoproterenol, a β-adrenergic receptor agonist.
Results: Twelve hours of hypoxia-induced caspase-3 cleavage, which was inhibited by treatment with insulin, while pre-treatment with
isoproterenol abolished the insulin effect. Hypoxia-induced cleavage of caspase-3 was mediated by p38 mitogen-activated protein kinase
(MAPK). Insulin inhibited hypoxia-induced phosphorylation of p38 through MAPK phosphatase-1 (MKP-1). Insulin-induced MKP-1
expression was mediated by extracellular signal-regulated protein kinases (ERK) 1/2, c-Jun NH2-terminal kinases (JNK) MAPK, and
phosphatidylinositol 3-kinase (PI3K)/Akt pathways. Isoproterenol stimulation failed to induce expression of MKP-1; moreover, insulin
resistance induced by long-term β-adrenergic stimulation inhibited insulin-evoked expression of MKP-1 by impairing insulin-induced
phosphorylation of both ERK1/2 and JNK without affecting Akt kinase activity. Furthermore, concomitant activation of Akt, ERK 1/2, and
JNK was required for insulin to exert its protective effect against the hypoxia-induced cleavage of caspase-3.
Conclusions: The results of this study lead to the conclusions that, in cardiac myocytes, antiapoptotic signals induced by insulin are mediated
by more than one signaling pathway, and that long-term β-adrenergic receptor stimulation impairing some of these pathways affects the
cytoprotective action of insulin.
© 2007 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.LE on M
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Insulin resistance is characterized by the reduced ability
of insulin to stimulate the uptake and disposal of glucose by⁎ Corresponding author. Dipartimento di Medicina Clinica, Scienze
Cardiovascolari ed Immunologiche, Università Federico II, Napoli, Italy,
Via S. Pansini n. 5, 80131 Napoli, ITALY. Tel./fax: +39 081 7462256.
E-mail address: cmorisco@yahoo.com (C. Morisco).
0008-6363/$ - see front matter © 2007 European Society of Cardiology. Publishe
doi:10.1016/j.cardiores.2007.07.012muscle [1], and is a common feature of diabetes mellitus [2],
hypertension [3], obesity [4], and metabolic syndrome [5].
Insulin resistance is accompanied by an impairment of
cardiac function and observed in heart failure and dilated
cardiomyopathy [6]. It is noteworthy that some of these
conditions are characterized by dysregulation of the
sympathetic nervous system [7–9], resulting in enhanced
stimulation of adrenergic receptors (ARs). However, in the
heart, pathophysiological consequences of the cross-talkd by Elsevier B.V. All rights reserved.
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 between the sympathetic nervous system and the insulin
sensitivity remain unclear.
Insulin is a pleiotropic hormone and regulates several
biological processes. In particular, insulin protects cardiac
myocytes from oxidative stress-induced apoptosis through a
phosphatidylinositol 3 kinase (PI3K)/Akt-dependent pathway
[10]. Since loss of cardiomyocytes by apoptosis plays a pivotal
role in the pathogenesis of left ventricular dysfunction [11],
elucidating whether insulin resistance impairs the cytoprotec-
tive effect of insulin is crucial for better understanding of the
mechanism mediating the development of left ventricular
dysfunction in patients with insulin resistance [12].
In cardiac myocytes, ligand binding of catecholamines to
β ARs induces apoptosis [13], as well as insulin resistance
[14]. Interestingly, both β ARs and the insulin receptor share
the PI3K/Akt pathway which exerts an antiapoptotic effect,
suggesting that additional mechanisms are required for
insulin to exert its protective effect. The MAPK superfamily
plays an important role in the regulation of apoptosis [15].
Recent evidence indicates that the family of enzymes known
as MAPK phosphatases (MKPs), which inactivate MAPKs
via dephosphorylation, is involved in the regulation of
apoptosis. Therefore, we hypothesized that the differential
regulation of MAPK and MKPs by insulin and β AR
stimulation may account for the cytoprotective action of
insulin.
This study was performed in order to: 1) explore whether
the condition of insulin resistance induced by β AR
stimulation affects the cytoprotective effect of insulin; 2)
better clarify the molecular mechanism, which is involved in
the cytoprotective effect of insulin but is eventually compro-
mised by β AR stimulation-induced insulin resistance.
2. Methods
2.1. Primary cultures of neonatal rat ventricularcardiomyocytes
The procedures involving animals were performed with
the approval of the animal reviewer board of our Institution.
Primary cultures of neonatal cardiomyocytes were prepared
as described [16]. The investigation conforms to the Guide
for the Care and Use of Laboratory Animals published by the
US National Institutes of Health. Cells were cultured in the
cardiac myocyte culture medium containing Dulbecco'sFig. 1.A)Morphological changes in cardiacmyocytes induced byhypoxia, obtained by
morphological changes of apoptosis. Many dead cells were also observed (midd
morphological changes (right panel). B) Insulin reduces hypoxia-induced apoptosis.
exposed to hypoxia for 12 h in the presence or absence of insulin (100 nM). Insulin
10μM, 2 h before insulin exposure). Cells were stainedwith annexin-V-fluorescein (gr
The percentage of apoptotic and necrotic cells was calculated by dividing the number
with the total number of nuclei detected with DAPI staining, respectively (right). Sti
apoptosis. Values represent themean±SEMof four culture preparations. ⁎pb0.05 vs c
3 cleavage. Cleavage of caspase-3 was assessed by immunoblot analysis. Treatment
hypoxia-induced caspase-3 cleavage. A representative immunoblot is shown. Bar grap
protein cleavage over that in unstimulated cells, of four independent experiments permodified Eagle's medium/Ham's F-12 supplemented with
5% horse serum, 4 μg/mL transferrin, 0.7 ng/mL sodium
selenite, 2 g/L bovine serum albumin (fraction V), 3 mmol/L
pyruvic acid, 15 mmol/L HEPES, 100 μmol/L ascorbic acid,
100 μg/mL ampicillin, 5 μg/mL linoleic acid, and 100 μmol/
L 5-bromo-2′-deoxyuridine.
The cells, after overnight starvation, were exposed to
hypoxia. Hypoxia was induced in a medium saturated
previously for 10 min at 1 atm with 95% N2 and 5% CO2,
and containing (mM) concentrations of 116 NaCl, 5.4 KCl,
0.8 MgSO4, 26.2 NaHCO3, 1 NaH2PO4, 1.8 CaCl2, and
0.01 glycine and 0.001 (% w/v) phenol red using a hypoxia
chamber (temperature: 37 °C, atmosphere: 5% CO2 and
95% N2) [17] The pH, PO2 and PCO2 of the medium
resulted to be 7.36±0.2, 45.3±1.2 mm Hg, 35.3±0.8 mm
Hg, and 7.32±0.9, 32.6±1.1 and 37.9±2.1 mm Hg, before
and at the end of hypoxia, respectively.
2.2. Immunoblotting
For detection of cleaved caspase-3, cells were lysed with
100 μL of ice-cold lysis buffer A (see Supplementary data).
For phospho-ERK 1/2, phospho-JNK, phospho-p38, and
MKP-1 detection, cells were lysed with 100 μL of ice-cold
lysis buffer B (see Supplementary data). Cleavage of
caspase-3, phosphorylation of ERK 1/2, JNK, and p38
MAPK, expression of MKP-1 were detected by immunoblot
analyses, using specific primary antibodies.
2.3. Akt kinase activity assay
Kinase activity of Akt was measured by the immune
complex kinase assay as we have previously described [18].
2.4. Glucose uptake assays
Cardiomyocytes were grown in twelve-well plates
(0.5×106 cells/well). 2-Deoxyglucose (2DG) uptake was
determined as described [14].
2.5. Adenovirus transduction
Adenovirus harboring dominant negative Akt (Ad5 CMV
Akt (K179M)) was obtained from Professor G. Condorelliphase-contrastmicroscopy. Twelve hours of hypoxia induced the characteristic
le panel). Insulin treatment completely prevented the occurrence of these
Cardiac myocytes were incubated with serum-free medium overnight and then
stimulation was conducted in the presence and absence of isoproterenol (ISO,
een), and propidium iodide (PI) (red), and counterstained by DAPI (blue) (left).
annexin-V-positive/ PI-negative cells and annexin-V-positive/PI-positive cells
mulation (30 min) with chelerythrine (6 μM) was used as positive control for
ontrol, ^pb0.05 vs hypoxia. C) Insulin reduces hypoxia-induced (12 h) caspase-
with Ins (100 nM) reduced, while ISO (10 μM) did not affect the amount of
h represents densitometric analysis, mean±SEM, expressed as fold increase in
formed in triplicate.
 2, 2012
455C. Morisco et al. / Cardiovascular Research 76 (2007) 453–464(University of California, San Diego, USA). Adenovirus
harboring lacZ (Ad5·CMV-β-galactosidase) was used as
a control. The method of adenovirus infection has been
described [19].2.6. Annexin-V staining
Cardiac myocytes growth on coverslips were stained with
Annexin-V-fluorescein+propidium iodide (Annexin-V- at FA
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Fig. 2. A) Hypoxia stimulates 2-Deoxyglucose (2 DG) uptake and abolishes
the ability of insulin to promote 2 DG uptake. Cardiac myocytes were
stimulated with insulin (Ins, 100 nM, 30 min), isoproterenol (ISO, 10 μM,
2 h) and ISO (2 h)+Ins (30 min) during normoxia and hypoxia (12 h). The
values of 2 DG uptake (cpm) in each experiment were adjusted by the
protein content of the dish (μg). The graph shows the mean±SEM of four
independent experiments performed in triplicate. B) Cardiac myocytes were
exposed to hypoxia in media with (Glu +) and without glucose (Glu −), in
the presence or absence of insulin (Ins, 100 nM). Cleavage of caspase-3 was
assessed by immunoblot analysis. A representative immunoblot is shown.
Bar graph represents densitometric analysis, mean±SEM expressed as fold
increase in protein cleavage over that in unstimulated cells, of three
independent experiments.
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 FLUOS Staining Kit, Roche) according the instructions of
the manufacturer. Cells undergoing early apoptosis were
stained with Annexin V, but not with propidium iodide (PI),
while necrotic cells or cells in late apoptosis stages were
stained with both annexin-V and PI.
2.7. Cardiac myocytes morphological analysis
Cell morphology was examined by phase-contrast
microscopy as previously reported [20].
2.8. Statistics
Data are given as mean±SEM. Statistical analyses were
performed using the analysis of variance. The post-test com-parison was performed by the method of Tukey. Significance
was accepted at pb0.05 levels.
3. Results
3.1. Hypoxia induces morphological changes and cleavage
of caspase-3 in cardiac myocytes with insulin resistance
Cardiac myocytes were subjected to hypoxia for 12 h in
the presence or absence of insulin. Hypoxia-induced
characteristic morphological changes of apoptosis, such as
pyknosis, vacuolization, and cell shrinkage. Furthermore,
many round, floating cells, and few remaining adherent cells
were detected (Fig. 1A). Morphology of myocytes treated
with insulin before hypoxia was quite similar to that detected
in control conditions. Hypoxia significantly increased the
percentage of both annexin-V positive/PI-negative and
annexin-V positive/PI-positive cardiac myocytes (Fig. 1B).
Insulin treatment before hypoxia significantly reduced the
rate annexin-V positive/PI-negative, while unaffected the
rate of annexin-V positive/PI-positive cells. To determine
whether or not the condition of insulin resistance compro-
mises the cytoprotective of insulin on hypoxia-induced cell
death, cardiac myocytes were stimulated 2 h before insulin
exposure with isoproterenol (ISO, 10 μM), a β AR agonist.
ISO stimulation abolished the ability of insulin to reduce the
percentage of hypoxia-induced annexin-V positive/PI-nega-
tive cells.
Hypoxia-induced myocyte death was associated with
cleavage of caspase-3. Immunoblot analyses showed that, in
control conditions cleaved caspase-3 was undetectable, while
hypoxia enhanced the amount of cleaved caspase-3 by 7 fold,
and insulin treatment reduced hypoxia-induced caspase-3
cleavage (Fig. 1C).
To determine whether or not the condition of insulin
resistance compromises the protective effect of insulin on
hypoxia-induced cleavage of caspases, cardiac myocytes
were stimulated 2 h before insulin exposure with ISO
(10 μM). During normoxia, cardiacmyocytes stimulated with
ISO did not show increases in the amount of cleaved caspase-
3, while the exposure of cells to ISO and insulin followed by
hypoxia dramatically increased the amount of cleaved
caspase-3 (Fig. 1C).
These results show that in neonatal cardiac myocytes
hypoxia induces morphological and biochemical changes
consistent with both apoptosis and necrosis, that insulin
prevents the occurrence of apoptosis, and that β AR stimu-
lation-induced insulin resistance inhibits the protective effect
of insulin on hypoxia-induced apoptosis.
3.2. Glucose is not required for the protective effect exerted
by insulin
Since glucose uptake reduces hypoxia-induced apoptosis
in cardiac myocytes [21] we hypothesized that the absence of
insulin-evoked reduction of hypoxia-induced caspase-3
Fig. 3. A) Hypoxia selectively induces the phosphorylation of p38 MAPK. Cardiac myocytes were exposed to hypoxia for the indicated times. Phosphorylation
of ERK 1/2, JNK and p38 MAPK was detected by immunoblotting. B) Insulin inhibits hypoxia-induced phosphorylation of p38 MAPK. Cardiac myocytes were
exposed to hypoxia in the presence or absence of insulin (Ins, 100 nM). Phosphorylation of p38 MAPK was detected by immunoblotting. C) Cardiac myocytes
were exposed to hypoxia in the presence or absence of an inhibitor of p38 MAPK, SB203580 (10 μM, 60 min before insulin exposure). Cleavage of caspase-3
was assessed by immunoblot analysis. Representative immunoblots of four independent experiments are shown. Bar graph represents densitometric analysis,
means±SEM expressed as fold increase in phosphorylation or cleavage over that in unstimulated cells.
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 cleavage during β AR-induced insulin resistance is due to an
impairment of insulin-stimulated glucose uptake. Therefore,
we measured insulin-stimulated 2-Deoxyglucose (2DG)
uptake during normoxia and hypoxia in the presence orabsence of β AR stimulation. During normoxic conditions,
as expected, insulin increased 2DG uptake by 80% (pb0.01,
vs control), and 2 h of ISO stimulation inhibited this
response (Fig. 2A). Twelve hours of hypoxia increased 2DG
Fig. 4. A) Insulin time-dependently stimulates MKP-1 protein expression. Cells were exposed to insulin (Ins) for the times indicated. MKP-1 protein expression
was assessed by immunoblot analysis using anti-MKP-1 antibody. B) Hypoxia does not affect insulin-induced MKP-1 protein expression. Cells were stimulated
with Ins and exposed to hypoxia for the indicated times. MKP-1 protein expression was assessed by immunoblot analysis. C) β AR stimulation-induced insulin
resistance inhibits insulin-evoked MKP-1 protein expression. Insulin resistance was induced by pre-treating cardiomyocytes with isoproterenol (ISO) 2 h before
insulin exposure. MKP-1 protein expression was assessed by immunoblot analysis. D) MKP-1 accounts for insulin-induced p38 MAPK dephosphorylation.
Cardiac myocytes were exposed to hypoxia in the absence or presence of insulin, and Ro-31-8220 (5 μM), an inhibitor of MKP-1. E) MKP-1 is involved in
insulin inhibition of hypoxia-induced caspase-3 cleavage. Cardiac myocytes were exposed to hypoxia in the absence or presence of insulin, and Ro-31-8220.
Representative immunoblots of four independent experiments are shown. Bar graphs represent densitometric analysis, mean±SEM, expressed as fold increase in
protein expression or phosporylation or cleavage over that in unstimulated cells.
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 uptake (530%, pb0.001 vs control normoxia) and compro-
mised insulin-stimulated 2DG (538%, p: NS vs control
hypoxia) (Fig. 2A). Furthermore, ISO stimulation in the
presence or absence of insulin did not affect 2DG uptake
compared to control conditions. These results show that
hypoxia dramatically increases glucose uptake and blunts the
effects of hormonal stimulation. Next, we examined whetheror not glucose is required for the protective effect of insulin
on hypoxia-induced cleavage of caspases. For this purpose,
cardiac myocytes were exposed to hypoxia in the presence or
absence of glucose (5.5 mM) in the culture media. Hypoxia
induced the cleavage of caspase-3, and insulin treatment
prevented this response independently from the presence of
glucose in the culture media (Fig. 2B).
459C. Morisco et al. / Cardiovascular Research 76 (2007) 453–4643.3. Hypoxia-induced caspase-3 cleavage is mediated by
phosphorylation of p38 MAPK
Since MAPK mediates cardiomyocyte apoptosis during
ischemia and/or reperfusion [22], we determined whichMAPKFig. 5. A) Insulin-induced MKP-1 protein expression is an ERK1/2- and
JNK-dependent phenomenon. Cardiac myocytes were stimulated with
insulin (Ins, 12 h) in the absence or presence of ERK 1/2 inhibitor, PD98059
(20 μM, 60 min before Ins exposure), JNK inhibitor, SP600125 (10 μM,
60 min before Ins exposure) and p38 inhibitor, SB203580 (10 μM, 60 min
before Ins exposure). MKP-1 protein expression was assessed by
immunoblot analysis. B) Insulin-induced MKP-1 protein expression also
requires a PI3K-dependent pathway. Cardiac myocytes were stimulated with
Ins in the absence or presence of 2 different inhibitors of PI3K, wortmannin
(10 nM, 30 min before Ins exposure) and LY290042 (10 μM; 30 min before
Ins exposure). MKP-1 protein expression was assessed by immunoblot
analysis. C) Akt is required for insulin-induced MKP-1 protein expression.
Cardiac myocytes were infected with adenovirus harboring a dominant
negative mutant of Akt (DN Akt, 10 MOI) or Lac Z, further cultured for
48 h, and then stimulated with Ins for 12 h. MKP-1 protein expression was
assessed by immunoblot analysis. Representative immunoblots of three
independent experiments are shown. Bar graphs represent densitometric
analysis, mean±SEM, expressed as fold increases in protein expression over
that in unstimulated cells.
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 mediates hypoxia-induced caspase-3 cleavage, and then
whether insulin affects the molecular pathway that accounts
for hypoxia-induced caspase-3 cleavage. Hypoxia did not affect
the phosphorylation of either ERK or JNK, but, did induce
phosphorylation of p38 MAPK (Fig. 3A), which was inhibited
by insulin (Fig. 3B). To determine whether activation of p38
MAPK accounts for hypoxia-induced cleavage of caspase-3,
cardiomyocytes were pre-treated with SB203580 (10 μM), an
inhibitor of p38MAPK.Hypoxia-induced cleavage of caspase-3
was abolished by treatment with SB203580 (Fig. 3C), sug-
gesting that p38 MAPK plays a critical role in mediating
hypoxia-induced activation of caspase-3.
3.4. Hypoxia-induced phosphorylation of p38 MAPK is
inhibited by insulin through a MKP-1 dependent pathway
MKP-1, a member of a family of enzymes known as
MAPK phosphatases, plays a critical role in the negative
regulation of p38 MAPK and promotes cell survival [23].
Therefore, we examined whether or not MKP-1 accounts for
insulin inhibition of hypoxia-induced phosphorylation of
p38 MAPK. Insulin time-dependently induced protein
expression of MKP-1, which was first evident after 1 h of
stimulation and peaked after 12 h (Fig. 4A). Insulin-induced
expression of MKP-1 was also detectable during hypoxia
(Fig. 4B), while pre-treatment with ISO abolished insulin-
induced expression of MKP-1 (Fig. 4C). To verify whether
MKP-1 accounts for insulin-induced inhibition of hypoxia-
evoked phosphorylation of p38 MAPK, cardiomyocytes
were pre-treated with Ro-31-8220 (5 μM), an inhibitor of
MKP-1, and then stimulated with insulin. Ro-31-8220
abolished inhibition of hypoxia-evoked phosphorylation of
p38 induced by insulin (Fig. 4D), suggesting that MKP-1 is
critically involved in insulin-induced inactivation of p38
MAPK. Then, we examined whether MKP-1 accounts for
insulin-induced inhibition of hypoxia-evoked casapase-3
cleavage. Pre-treatment with Ro-31-8220 (5 μM) abolished
inhibition of hypoxia-evoked caspase-3 cleavage induced by
Fig. 6. Long-term β AR stimulation does not inhibit insulin-stimulated Akt kinase activity (top). Cardiac myocytes were pre-treated with or without ISO for 2 h
and then stimulated with Ins for 20 min. The kinase activity of Akt was determined by the immune complex kinase assay using paramyosin-GSK3α (peptide 7-
25) fusion protein as a substrate. GSK3α (peptide 7-25) phosphorylated at Ser-21 was quantified by immunoblot analysis using the anti-phospho GSK3α/β (Ser-
21/Ser-9) antibody. IP indicates immunoprecipitation. Long-term β AR stimulation inhibits insulin-induced ERK 1/2 phosphorylation (middle). Cardiac
myocytes were pre-treated with ISO for 2 h and then stimulated with Ins for 10 min. Phosphorylation of ERK 1/2 was assessed by immunoblot analysis using
anti-phospho-ERK 1/2 antibody. Long-term βAR stimulation time-dependently inhibits insulin-induced JNK phosphorylation (bottom). Cardiac myocytes were
pre-treated with ISO for 2 h before Ins stimulation (30 min). Phosphorylation of JNK was assessed by immunoblot analysis using anti-phospho-JNK antibody.
Representative immunoblots of four independent experiments are shown. Bar graph represents densitometric analysis, mean±SEM, expressed as fold increase in
phosphorylation over that in unstimulated cells.
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 insulin, suggesting that MKP-1 is critically involved in
cytoprotective effect of insulin (Fig. 4E).
3.5. Insulin-induced MKP-1 expression requires both ERK
and JNK MAPK, and PI3K/Akt pathways
We examined how insulin regulates MKP-1 protein
expression. MKP-1 induction is generally regulated by
MAPK family members [24], as well as by PI3K [25].
Therefore, to evaluate the potential contribution ofMAPK and
PI3K signaling pathways to insulin-mediated MKP-1 induc-
tion, myocytes were pre-treated with PD98059, a specific
MEK inhibitor, SP600125, an inhibitor of JNK, SB203580, a
specific inhibitor of p38 MAPK, wortmannin and LY290042,
two different inhibitors of PI3K, followed by insulin exposure.
Pre-treatment with PD98059, SP600125, wortmannin or
LY290042 completely blocked insulin-induced expression of
MKP-1 expression (Fig. 5A and B, respectively). In contrast,
SB203580, did not affect insulin-induced MKP-1 expression.
Akt is a serine/threonine kinase that regulates several PI3K-
dependent transcriptional activities. We examined the role of
Akt in mediating insulin-induced MKP-1 protein expression.
Myocytes were transduced with adenoviruses harboring
dominant negative (DN) Akt (10 MOI). DN Akt significantly
reduced insulin-induced expression ofMKP-1, suggesting that
Akt is required for MKP-1 expression (Fig. 5C).
Collectively, insulin regulates MKP-1 expression through
a complex pathway which includes both ERKs and JNK
MAP kinases, and the PI3K/Akt pathway.
3.6. β AR stimulation-induced insulin resistance compromises
insulin-evoked MKP-1 expression by inhibiting ERK1/2 and
JNK phosphorylation
Since MKP-1 is involved in the cytoprotective action
of insulin, we determined whether β AR-induced insulinresistance compromises insulin-evoked MKP-1 protein
expression. First, β AR stimulation failed to induce
expression of MKP-1 (data not shown). On the other hand,
insulin resistance induced by long-term stimulation of β AR
inhibited insulin-evoked expression of MKP-1 (Fig. 4C).
Next, we explored the molecular pathway that accounts for
impaired expression of MKP-1 during β AR-induced insulin
resistance. In cardiac myocytes, insulin-induced MKP-1
expression is regulated by both ERK and JNK MAPK, and
by the PI3K-dependent pathway. Therefore, we examined
whether β AR-induced insulin resistance affects insulin
signaling involved in the expression of MKP-1. Long-term
stimulation (120 min) with ISO inhibited insulin-induced
phosphorylation of both ERK 1/2 and JNK, but did not affect
the insulin-evoked kinase activity of Akt (Fig. 6). These data
indicate that β AR-stimulation-induced insulin resistance
compromises an arm of the molecular pathway that is
involved in the expression of insulin-induced MKP-1.
3.1. Akt and phosphorylation of ERK1/2 and JNK are
required for the protective effect of insulin
Since the protective action of insulin against hypoxia-
induced caspase-3 cleavage is mediated by MKP-1, whose
expression is regulated by PI3K/Akt-, ERK1/2-, and JNK-
dependent mechanisms, we asked if these three components
involved in insulin-induced MKP-1 expression are also
required for the protective action of insulin. Inhibition of
Akt activity was obtained by overexpression of a dominant
negative mutant of Akt, while ERK 1/2 and JNK were
inhibited by PD98059 and SP600125, respectively. Ade-
novirus-mediated expression of the dominant negative
mutant of Akt abolished the effect of insulin on hypoxia-
induced caspase-3 cleavage (Fig. 7A). Similarly, pre-treat-
ment of cardiac myocytes with either PD98059 or SP600125
abolished the effect of insulin on hypoxia-induced caspase-3
461C. Morisco et al. / Cardiovascular Research 76 (2007) 453–464
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requires simultaneous activation of Akt, ERK 1/2 and JNK
to exert its protective effect against the hypoxia-induced
cleavage of caspase-3.
4. Discussion
Insulin resistance is a common feature of several diseases
which increase the cardiovascular risk, and, at the same time,
worsen the prognosis of ischemic heart disease. Several at FA
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 pathogenic mechanisms account for the worsening of the
cardiovascular prognosis during insulin resistance. However,
it is still unknown whether the condition of insulin resistance
compromises the cytoprotective action of insulin. In this
study we demonstrated that in neonatal cardiac myocytes:
1) insulin prevents hypoxia-evoked caspase-3 cleavage,
2) the cytoprotective action of insulin on hypoxia-induced
caspase-3 cleavage requires MKP-1, 3) insulin-induced
MKP-1 expression is mediated by ERK 1/2 and JNK
MAPK and PI3K/Akt pathways; 4) βAR stimulation-induced
insulin resistance compromises the cytoprotective action of
insulin by impairing ERK 1/2 and JNK phosphorylation.
Caspases play a key role in the regulation of apoptosis,
and caspase-3 is known to be an important molecule in the
cellular suicide cascade [26]. Hypoxia is one of the
components of ischemia and previous reports have docu-
mented apoptosis in cardiac myocytes subjected to hypoxia
[27,28]. Although in some cell types mild hypoxia can
induce cellular phenotype more resistant to acute metabolic
stress [29] and then, mimic the effect of cytoprotective
agents, here we found that treatment with insulin prevents
cleavage of caspase-3 evoked by a severe hypoxia. This
observation is not trivial, since activation of caspase-3 also
impairs cardiac contractility by cleaving myofibrillar
proteins and decreasing the myofibrillar ATPase activity
[30]. Thus, the protective effect of insulin on hypoxia-
induced caspase-3 cleavage could be not limited to just the
reduction of apoptosis but also include the preservation of
cardiac contractility. In contrast, the condition of insulin
resistance, by impairing the protective effect of insulin on
caspase-3, can worsen the cellular response to hypoxia by
enhancing the degree of apoptosis and by inducing con-
tractile dysfunction.
Several mechanisms can account for the antiapoptotic
action of insulin. For instance, glucose uptake and glycolysis
protect cardiac myocytes from hypoxia-induced apoptosis
[21]. Our results indicate that insulin exerts its protective
action during hypoxia independently of glucose uptake, since
the insulin-mediated reduction of hypoxia-induced caspase-3
cleavage was also obtained in the absence of glucose in cultureFig. 7. A) Overexpression of a dominant negative mutant of Akt
compromises the effect of insulin on hypoxia-induced cleavage of
caspase-3. Twenty-four hours after plating, myocytes were infected with
adenovirus harboring a dominant negative mutant of Akt (DN Akt), 10
MOI) or Lac Z, and further cultured for 48 h, then were exposed to hypoxia
(12 h) in the presence or absence of insulin (Ins, 100 nM). B) ERK 1/2
inhibition compromises the effect of insulin on hypoxia-induced caspase-3
cleavage. Cardiac myocytes were exposed to hypoxia in the presence or
absence of insulin. Inhibition of ERK 1/2 was obtained by pre-treating cells
with PD98059 (20 μM). C) JNK inhibition compromises the effect of insulin
on hypoxia-induced caspase-3 cleavage. Cardiac myocytes were exposed to
hypoxia in the presence or absence of insulin. Inhibition of JNK was ob-
tained by pre-treating cells with SP600125 (10 μM). Cleavage of caspase-3
was assed by immunoblot analysis. Representative immunoblots of five
independent experiments are shown. Bar graphs represent densitometric
analysis, mean±SEM expressed as fold increase in protein cleavage over
that in unstimulated cells.
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 media. Our results do not rule out the possibility that glucose
uptake and metabolism are protective for ischemic myocardi-
um but indicate that the protective action of insulin is a
multifactorial and complex process due to the activation of
different antiapoptotic pathways, including insulin-induced
glycogen and ATP sparing, cross-activation of insulin-like
growth factor 1, bad phosphorylation. In this regard, insulin
protects neonatal cardiac myocytes from oxidative stress-
induced apoptosis through two different pathways, PI3
Kinase/Akt and ERKs, which are independently activated,
and these two pathways may exert their protective action in a
cooperative fashion, by phosphorylating different serine
residues of Bad [10]. Our data seems to further extend this
hypothesis since parallel pathways are required for the insulin-
induced inhibition of hypoxia-evoked caspase-3 cleavage and
do not act in cooperative fashion. In fact, we found that
hypoxia induces cleavage of caspase-3 through a p38 MAPK-
dependent pathway, and insulin stimulation of the expression
of MKP-1, which dephosphorylates p38 MAPK, inhibits this
phenomenon (Fig. 8). Our data does not rule out the possibility
that insulin exerts its protective effect by the synergistic actions
of PI3K/Akt and ERK 1/2 on Bad phosphorylation, but does
describe another molecular mechanism involving expression
of MKP-1 that contributes to the protective effect of insulin.
Although MKP-1 is involved in the regulation of several
physiological functions, such as gene expression, cell growth,
apoptosis, and immune responsiveness [31], the importance of
MKP-1 in mediating the regulation of these processes remainsFig. 8. Current hypothesis as to how stimulation of β AR-induced insulin resistance
Hypoxia induces cleavage of caspase-3 though p38 MAPK-dependent pathway. Ins
in turn, promote the expression of MKP1, a MAPK phosphatase, that inactivates p
receptor function through Akt, and, thus, removes the inhibitory effect of insuli
negative regulation of pathway).unclear. Here we report that MKP-1 plays a pivotal role in the
protective action of insulin. Our data is consistent with that of
Wu [23], who showed in primarymouse embryonic fibroblasts
thatMKP-1 promotes cell survival by attenuating p38MAPK-
mediated activation of caspase-3 and apoptosis. Furthermore,
the protective role ofMKP-1 has been also reported in vivo. In
particular, Kaiser et al. have demonstrated that, in both
cultured neonatal cardiomyocytes and the adult heart, p38
MAPK functions as a pro-death signaling effector, and that
enhanced expression of MKP-1 protects the heart from p38-
dependent injury [32]. Altogether, these data support the con-
cept that MKP-1 plays a key role in insulin-mediated cellular
protection.
In cardiac myocytes, insulin-induced MKP-1 protein ex-
pression is a complex phenomenon which requires ERK 1/2,
JNK MAPK and PI3K/Akt pathways. β AR-induced insulin
resistance compromises this molecular machinery. We found
that β AR stimulation activates the molecular pathways
involved in insulin-induced MKP-1 expression only in part
and with different kinetics. Actually, ISO induced a shorter
ERK 1/2 phosphorylation compared to that induced by
insulin and failed to activate JNK (see Supplementary data).
Furthermore, we found that sustained β AR stimulation
impaired insulin-induced ERK 1/2 and JNK phosphorylation,
while it did not affect insulin-induced Akt activity. Thus, it is
possible that, in cardiac myocytes, β AR stimulation induces
only partial phosphorylation/activation of protein kinases
involved inMKP-1 transcription. On the other hand, long-termcompromises the protective effect of insulin on hypoxia-induced apoptosis.
ulin stimulation phosphorylates/activates Akt, ERK and JNKMAPK, which,
38 MAPK Sustained β AR stimulation exerts a detrimental effect on insulin
n on hypoxia-induced caspase-3 cleavage/activation (dashed lines indicate
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 stimulation of β AR by impairing insulin receptor function
[14] inhibits insulin-induced ERK 1/2 and JNK activation.
This compromises the protective machinery activated by
insulin. These results suggest that phosphorylation/activa-
tion of Akt or ERK 1/2 is not capable of preventing hypoxia-
induced caspase-3 cleavage. Our data are apparently in
contrast with the notion that overexpression of Akt [33,34]
or ERK [35] is sufficient to protect cardiac myocytes from
apoptosis. However, it should be noted that this concept
comes from experimental models characterized by the
overexpression of a single antiapoptotic kinase, presumably
associated with the integrity of the other antiapoptotic
pathways, while our observation is obtained in an
experimental model in which one arm of the insulin-
activated antiapoptotic pathway is impaired.
In summary, antiapoptotic signals induced by insulin are
mediated bymore than one signaling pathway, and long-termβ
adrenergic receptor stimulation impairs these pathways,
thereby inhibiting the cytoprotective action of insulin (Fig. 8).
This has important pathophysiological implications since one
of the main goals of treatment for cardiovascular diseases is to
preserve cardiac contractility. This can be achieved in an
experimental model by reduction of apoptosis, attained by
inhibition of caspase activities [36,37]. It is possible to
speculate that all treatments that are able to interfere with the
development of insulin resistance, or, alternatively, increase the
insulin sensitivity, in cardiovascular diseases may be beneficial
for survival of cardiac myocytes and increased contractility.
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